Product Images Lacosamide

The text is a figure displaying the median percent reduction in seizure frequency per 28 days from baseline to the maintenance phase by dose. The figure includes data from studies 2, 3, and 4 for various doses of different tablets such as Lacosamide tablets and Placebo. The figure shows statistical significance for some treatments compared to placebo.*

This is a table that provides information on Responder Rate, Improvement, and Worsening in relation to different dosages of Lacosamide and Placebo. The Responder Rate is presented as a percentage varying between 0% and 100%. Improvement and Worsening are also presented, with percentages ranging from -50% to +50%. The data is broken down into different dosage groups: Placebo (N=359), Lacosamide 200mg/day (N=257), Lacosamide 400mg/day (N=465), and Lacosamide 600mg/day (N=202).*

Each tablet contains 50mg of lacosamide, USP. The NDC code for this is 51991-348-06. The usual dosage is to be determined by referring to the package insert or using prescribing information, see MLNo. 5/MN/TS/2014/F/G. The tablets should be stored at temperatures between 20°C to 25°C (65°F to 77°F) but excursions are permitted between 15°C to 30°C (59°F to 86°F). The medication should be dispensed with the accompanying medication guide to each patient. Distributed by Breckenridge Pharmaceuticals and manufactured by MSN Laboratories Private Limited, ATowa v Mg Soosmn ria, with 60 tablets per pack.*

Each tablet contains 150mg of Lacosamide, USP, and has NDC 51991-350-08. The usual dosage is 3 tablets, with storage instructions between 20°C to 25°C (66°F to 77°F), and excursions suggested between 15°C to 30°C (55°F to 86°F). The medication should be accompanied by a guide from the pharmacist and dispensed to each individual patient. This tablet product, containing 60 tablets, is distributed by Recknridge pharmaceutics located in Berlin, CT 06037. The text also includes regulatory information such as MLNo: 5/ADN/TS/014/F/G, Tablets, USP Rev 10/2021, and Controlled Room Temperature, but the purposes of which could not be discerned.*

Exch tablet is a medication that contains 200mg with NDC number 51991-351-06. The tablet is called Lacosamide, and its strength is USP, and the recommended storage temperature is between 15°C to 30°C (59 to 86°F), and may be tolerated in temperatures between 20°C to 25°C (65°F to 77°F). The medication should be dispensed with the guidance of a pharmacist and the patient's guide. The manufacturer of the tablet is ASN. Lubosatoses Private Limited and it comes in a pack of 60 tablets.*